Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term continuous ambulatory peritoneal dialysis

N V Dombros1, G E Digenis, E V Balaskas

  • 1Peritoneal Dialysis Program, Toronto Western Hospital, Ontario, Canada.

Clinical Nephrology
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twice-daily icodextrin for ultrafiltration failure.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2011
Same author

Is professional courtesy dying?

Canadian Medical Association journal·2010
Same author

Know history of CAPD accurately.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2009
Same author

Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature.

Clinical nephrology·2009
Same author

Intravenous iron sucrose changes the intraperitoneal homeostasis.

Blood purification·2009
Same author

The effect on renal structure and function of late-life-introduced caloric restriction (CR) in rats.

International urology and nephrology·2008

Continuous Ambulatory Peritoneal Dialysis (CAPD) can be a viable long-term treatment option for kidney failure. This study followed 10 patients on CAPD for over seven years, showing its feasibility and stability.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Renal Replacement Therapy

Background:

  • Continuous Ambulatory Peritoneal Dialysis (CAPD) is a treatment for end-stage renal disease.
  • Long-term outcomes and patient management on CAPD require further investigation.

Purpose of the Study:

  • To evaluate the long-term outcomes of patients undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD).
  • To assess the feasibility and patient stability during extended CAPD treatment periods.

Main Methods:

  • Retrospective analysis of 10 patients who remained on CAPD for at least seven years.
  • Monitoring of clinical parameters including body weight, ultrafiltration, laboratory values (BUN, creatinine, protein, albumin, hemoglobin, lipids), and renal osteodystrophy progression.
  • Tracking of peritonitis rates, catheter complications, and hospitalization rates.

Related Experiment Videos

Main Results:

  • Patients experienced a significant increase in body weight and a decrease in ultrafiltration capacity within the first three years.
  • Biochemical markers (BUN, creatinine, total protein, albumin, hemoglobin, lipids) remained relatively stable.
  • The peritonitis rate was one episode per 18.9 patient-months, with an average hospitalization of 8.76 days per patient-year, primarily for peritonitis.

Conclusions:

  • Continuous Ambulatory Peritoneal Dialysis (CAPD) can be successfully utilized for extended periods.
  • While challenges like weight gain and ultrafiltration changes exist, key biochemical parameters remain stable.
  • Careful management of peritonitis is crucial for long-term CAPD success.